Helena Iznardo

19PUBLICATIONS
30CO-AUTHORS
Molecular targetsPharmacogenomicsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 08, 2026
Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review.

|Jul 24, 2025
'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors.

Yordi-Michaël Bouhatous, Cecilie Bredrup, Agnes Maurer

|Mar 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Lía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román

|Jun 10, 2024
Periungual pyogenic granulomas after ravulizumab therapy in a child with acute myelomonocytic leukemia treated with hematopoietic stem cell transplant.

Helena Iznardo, Ivan López-Torija, Laura Mateu-Arrom

|Feb 25, 2023
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis.

Helena Iznardo, Esther Roé, Esther Serra-Baldrich

|Aug 26, 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Cristina Muniesa, Fernando Gallardo, Ignacio García-Doval

Pageof 4

Frequent Collaborators

10 joint publications

Luís Puig

3 joint publications

Eulalia Baselga

2 joint publications

Silvia Kalantari

2 joint publications

Cristina Muniesa